Bio-Path Stock Price (NASDAQ:BPTH)

Add to My Stocks
$0.93 $0.02 (2.11%) BPTH stock closing price Feb 21, 2017 (Closing)
Prev Close* : $0.95
Market Cap:
$90.66M
Day Low: $0.85
52 Week Low: $0.81
Open: $0.98
Volume: 83920
Day High: $1
52 Week High: $3.19
Dividend:
N/A

Latest Stock Market News

Latest Articles

Bio-Path News - From Partners

BPTH Stockcharts

View BPTH PE ratio, PS ratio stocks charts and compare with peers.
BPTH Chart
Note: Compare Bio-Path stock price history with the index and industry peers.

BPTH Industry Peers

Company Price Change (%)
Catalyst Pharma (CPRX)1.130.02 (1.74%)
Scynexis (SCYX)3.470.15 (4.14%)
Ariad Pharma (ARIA)23.990 (0%)
Macrogenics (MGNX)20.520.87 (4.07%)
Seattle Genetics (SGEN)65.680.18 (0.27%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Pdl Biopharma (PDLI)2.220.05 (2.2%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sucampo Pharma (SCMP)12.60.8 (6.78%)
Portola Pharma (PTLA)32.660.98 (3.09%)
Genocea Biosciences (GNCA)4.740.14 (3.04%)
Aratana Therapeutics (PETX)6.530.19 (3%)
Zogenix (ZGNX)10.50.3 (2.94%)
Nektar Therapeutics (NKTR)13.410.31 (2.37%)
Flexion Therapeutics (FLXN)19.660.43 (2.24%)
Top gainers from Medical-Drugs industry
* As of Feb 22, 2017
CompanyPriceChange (%)
BioCryst Pharma (BCRX)6.10.46 (7.01%)
CTI BioPharma (CTIC)4.460.27 (5.71%)
Ignyta (RXDX)9.10.5 (5.21%)
PTC Therapeutics (PTCT)13.50.66 (4.66%)
La Jolla Pharma (LJPC)18.090.88 (4.64%)
Cempra (CEMP)3.20.15 (4.48%)
Tetraphase Pharmaceuticals (TTPH)5.190.24 (4.42%)
Top losers from Medical-Drugs industry
* As of Feb 22, 2017

Bio-Path Financial Statements

income statement20152014201320122011
Net Sales Or Revenues-----
Net Income-5.46M-4.51M-3.26M-2.58M-2.36M
Total Operating Expense5.48M4.53M3.26M2.57M2.36M
view Bio-Path Holdings Inc income statement
balance sheet20152014201320122011
Total Assets10.75M15.47M5.07M2.34M3.23M
Total Liabilities0.93M0.56M0.29M0.32M0.31M
Shareholders Equity9.81M14.91M4.78M2.01M2.91M
view Bio-Path Holdings Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-0.1M0.12M0.08M-0.02M0.27M
Net Cash From (Used By) Operating Activities-5M-3.81M-2.31M-1.99M-1.14M
Increase (Decrease) In Prop Plant And Equipment--0.12M---
view Bio-Path Holdings Inc cashflow statement

Bio-Path Stock Message Board

An investor needs to spend 0.93 to buy BPTH stock, as the closing Bio-Path stock price is 0.93. Bio-Path market capitalization is 90.66M and it represents the total market value of BPTH stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Bio-Path stock analysis.

The terms stocks and shares mean the same thing. For Ex: Bio-Path stock price and Bio-Path share price mean the same thing. The volume of shares traded stood at 83920 on the last trading day, as is evident from Bio-Path stock chart, and BPTH stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. One can observe stock price trends and check for volatility by checking Bio-Path stock price history.